ADMA Biologics, Inc. · 3 months ago
Director, General Accounting and Internal Reporting
Boca Raton, FL
Full-time
Onsite
Director/Executive
12+ years expADMA Biologics is a biopharmaceutical company committed to creating superior products for immunodeficient patients at risk for infection. They are seeking a Director, General Accounting and Internal Reporting to manage the financial close process, ensure compliance with internal controls, and support SEC filings and audits.
BiotechnologyHealth CareManufacturingMedical
No H1B
Responsibilities
Prepares the monthly financial consolidation as the foundation for ADMA's external financial statements
Manages the financial close process to ensure financial statements can be prepared in accordance with ADMA's internal and external reporting requirements
Assists with the development, implementation and documentation of internal controls in support of ADMA 's Sarbanes-Oxley 404(b) requirements
Assists the Corporate Controller and CFO in monitoring the Company's cash balances and liquidity requirements
Oversee all revenue and accounts receivable transactions for pharmaceutical sales that are initiated by the third-party logistics company
Lead the Government Pricing analyst to coordinate Medicaid rebate processing and related issues, working closely with the Market Access group and third-party consultants
Reviews and approves balance sheet reconciliations on a timely basis
Reviews and assesses SAP modules to determine continuous process improvements. Implements and executes new functionalities in SAP
Training and development of accounting staff
Ensures adherence to ADMA's internal controls and accounting policies and procedures within and outside the Finance Department, identifying areas for improvement and greater efficiency
Works with cross-functional teams as required
Prepares and provides requested schedules to external auditors during interim reviews and year-end audits and assists the Controller in managing the audit process
Assist the Corporate Controller with SEC filings and ad hoc reporting requirements
Partner with the Finance team to lead our month end close optimization initiative
Qualification
Required
Bachelor's degree in accounting
CPA required
Requires 12+ years of professional related work experience
Requires proficiency in finance and office applications (SAP or other Tier I ERP applications, Excel, Word)
Must be financial/detail oriented
Possess excellent analytical abilities
Must be customer oriented
Must possess excellent communication skills
Ability to effectively manage staff
Ability to handle multiple priorities and tight deadlines
Understand concepts, requirements, and accounting issues for all business areas
Ability to follow the cGMP's and procedures with great attention to detail
Strong organizational, interpersonal and collaborative skills
Preferred
Experience in financial management, budgeting, AP, AR, and Government Pricing
Experience in the Medical and or Pharmaceutical industry
Proactive in identifying opportunities for process improvement and implementing effective solutions
Vigilant in maintaining compliance with all regulatory requirements and internal policies
Focused on achieving measurable outcomes and driving continuous improvement
Benefits
401K plan with employer match and immediate vesting
Medical, Vision, Life and Dental Insurance
Pet Insurance
Company paid STD and LTD
Company Paid Holidays
3 Weeks’ Paid Time Off (within the first year)
Tuition Assistance (after the first year)
Easily accessible to Tri-Rail
Free shuttle to the Boca Tri-Rail station
Company
ADMA Biologics, Inc.
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.04BKey Investors
JP MorganAres ManagementHayfin Capital Management
2025-08-06Post Ipo Debt· $300M
2023-12-18Post Ipo Debt· $135M
2022-12-07Post Ipo Equity· $60M
Leadership Team
Adam Grossman
Founder, President & CEO
Recent News
MarketScreener
2026-01-05
2025-11-07
Company data provided by crunchbase